Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak
Detection Principle
NucleicAcid-PCR based
Target
N, E, RdRp, genes
Testing Method Category
In_silico
Testing Method
WHO-5, WHO-3, WHO-7, WHO-1, QIAstat-Dx Respiratory SARS-CoV-2 Panel
Testing Method - Additional Info
evaluation of five SARS-CoV-2 PCR assay panels against the accumulated genetic variability of the virus to assess the effect on sensitivity of the individual assays
Sample Size
more than 33000 sequences
Peer-reviewed
yes
Related methods
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements